Global Active Implantable Medical Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

“Global Active Implantable Medical Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global active implantable medical devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global active implantable medical devices market report has been segmented on the basis of product and region.

Introduction:

Any active medical device which is intended to be totally or partially introduced by surgically or medical procedure into the human body, and which is intended to remain after the carrying out procedure is called as active implantable medical devices.

Market Dynamics:

Key factors expected to drive growth of the global active implantable medical devices market is increasing prevalence of chronic diseases such as cardiovascular, neurological diseases, etc. In addition, increasing healthcare expenditure, growing elderly population, rising governments funding for R&D activates and technological advancement, are among some other factors expected to drive growth of the target market. Furthermore, favorable reimbursement policies, increasing accessibility for healthcare facilities, rapid development of the healthcare sector, changing lifestyle, increasing awareness regarding cardiac diseases, are some other factors expected to drive growth revenue of the target market over the forecasted period. However, stringent regulatory approval and high cost of implants are factors expected to hamper growth of the global active implantable medical devices market to a certain extent in the forecast period.

Trends:

Major players are collaborating with other players in order to develop technologically advance product in order to cater the demand for minimal invasive treatment procedures. In addition, government of several countries are funding for carrying out R&D activities and trails for reducing the global burden of chronic diseases. For instance, in 2017, Cochlear Ltd. collaborated with Apple, Inc. in order to offer cochlear implants with iPhone connectivity, which was launched in July 2017.

Regional Analysis:

The market in North America is expected to dominate the global active implantable medical devices market. This is primarily attributed to rising prevalence of cardiovascular and chronic pain diseases in countries in the region. In 2017, according to the Centers for Disease Control and Prevention (CDC) around 2.7 to 6.1 Mn people in the US are suffering from atrial fibrillation, which is the most common type of heart arrhythmia. In contrast, the market in Asia Pacific is expected to be an emerging market for the global active implantable medical devices market, and is expected to register highest CAGR in during the forecasted period. This is primarily attributed to rising healthcare spending, growing healthcare infrastructural, increasing demand for advanced technologies in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register high growth revenue in the global active implantable medical devices market over the forecast period.

GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION:

Segmentation by product:

• Implantable Cardioverter Defibrillators
  • Transvenous Implantable Cardioverter Defibrillators
    • Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
    • Dual-Chamber Implantable Cardioverter Defibrillators
    • Single-Chamber Implantable Cardioverter Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators
• Ventricular Assist Devices
• Implantable Heart Monitors/Insertable Loop Recorders
• Neurostimulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulators
• Implantable Hearing Devices
  • Active Hearing Implants
  • Non-active/Passive Hearing Implants

 Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Medtronic plc.
• Abbott Laboratories
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• LivaNova PLC
• Cochlear Limited
• Sonova Holding AG
• William Demant Holding A/S
• Nurotron Biotechnology Co. Ltd.
• MED-EL